市場調査レポート

商品コード

1302044

C反応性蛋白質検査市場：アッセイタイプ、疾患領域、検出範囲、エンドユーザー別-2023-2030年の世界予測

C-Reactive Protein Testing Market by Assay Type, Disease Area, Detection Range, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

C反応性蛋白質検査の世界市場は大きく成長すると予測され、2023年には15億946万米ドル、CAGRは12.39%と予測され、2030年には34億2,540万米ドルに達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のC反応性蛋白質検査市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.C反応性蛋白質検査の世界市場規模および予測は？

2.予測期間中、世界のC反応性蛋白質検査市場を形成するCOVID-19の阻害要因と影響は？

3.C反応性蛋白質検査の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.C反応性蛋白質検査の世界市場における競争戦略は？

5.C反応性蛋白質検査の世界市場における技術動向と規制の枠組みは？

6.C反応性蛋白質検査の世界市場における主要ベンダーの市場シェアは？

7.C反応性蛋白質検査の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - さまざまな健康状態によって引き起こされる炎症を測定する必要がある
  - 慢性疾患の発生率の増加と高齢者人口の増加
  - 抗生物質を安全に減らすためのC反応性タンパク質のポイントオブケア検査の改善
- 抑制要因
  - より商業化された代替疾患検査法の利用可能性
- 機会
  - 従来のCRP検査の技術進歩
  - 犬の消化器疾患におけるC反応性タンパク質の調査
- 課題
  - 慎重な管理と取り扱いの要件
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章 C反応性蛋白質検査市場アッセイタイプ別

化学発光免疫測定法
- 遊離T3
- 遊離T4
- 甲状腺刺激ホルモンレベル
ELISA法
- 臨床
- 非臨床
免疫比濁法
ラジオイムノアッセイ
- 甲状腺刺激ホルモン受容体に対する自己抗体
- ヒト血清サイログロブリン自己抗体
- チロペルオキシダーゼ自己抗体

第7章 C反応性蛋白質検査市場疾患領域別

がん
心血管疾患
子宮内膜症
炎症性腸疾患
狼瘡
関節リウマチ

第8章 C反応性蛋白質検査市場検知範囲別

cCRP
従来のCRP
hs-CRP

第9章 C反応性蛋白質検査市場：エンドユーザー別

生活支援ヘルスケア施設
クリニック
- 実在物
  - 医師の診察室
  - 小規模クリニック
家
病院
研究室

第10章南北アメリカのC反応性蛋白質検査市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第11章アジア太平洋地域のC反応性蛋白質検査市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第12章欧州・中東・アフリカのC反応性蛋白質検査市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第13章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第14章掲載企業一覧

第15章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. C-REACTIVE PROTEIN TESTING MARKET RESEARCH PROCESS
FIGURE 2. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2022 VS 2030
FIGURE 3. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2022 VS 2030 (%)
FIGURE 5. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2022 VS 2030 (%)
FIGURE 6. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2022 VS 2030 (%)
FIGURE 7. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 8. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 9. C-REACTIVE PROTEIN TESTING MARKET DYNAMICS
FIGURE 10. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. C-REACTIVE PROTEIN TESTING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 19. C-REACTIVE PROTEIN TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. C-REACTIVE PROTEIN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 5. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 6. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T3, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T4, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROTROPIN LEVELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 11. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY NONCLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY IMMUNOTURBIDIMETRIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 16. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY AUTOANTIBODIES AGAINST THYROTROPIN RECEPTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HUMAN SERUM THYROGLOBULIN AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROPEROXIDASE AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 21. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LUPUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 28. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CCRP, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CONVENTIONAL CRP, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 34. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 36. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY SMALL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 70. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 72. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 73. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 74. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 75. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 76. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 78. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 81. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 82. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 84. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 117. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 118. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 119. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 120. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 121. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 122. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 123. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 125. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 126. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 127. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 128. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 129. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 130. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 131. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 132. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 134. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 144. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 145. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 146. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 147. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 148. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 149. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 150. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 152. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 198. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 199. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 200. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 201. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 202. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 203. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 204. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 206. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 226. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 227. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 228. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 229. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 230. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 231. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 232. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 234. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 235. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 236. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 237. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 238. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 239. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 240. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 241. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 243. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 244. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 245. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 246. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 247. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 248. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 249. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 250. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 252. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 253. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 254. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 255. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 256. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 257. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 258. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 259. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 261. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 262. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 263. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 264. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 265. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 266. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 267. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 268. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 270. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 280. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 281. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 282. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 283. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 284. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 285. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 286. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 288. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 300. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 301. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 307. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 308. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 309. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 310. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 311. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 312. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 313. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 315. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 316. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 317. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 318. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 319. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 320. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 321. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 322. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 324. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2030 (USD MILLION)
TABLE 325. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)

Product Code: MRR-A339DAEFABE9

The Global C-Reactive Protein Testing Market is forecasted to grow significantly, with a projected USD 1,509.46 million in 2023 at a CAGR of 12.39% and expected to reach a staggering USD 3,425.40 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global C-Reactive Protein Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global C-Reactive Protein Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Assay Type, market is studied across Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay, and Radioimmunoassay. The Chemiluminescence Immunoassay is further studied across Free T3, Free T4, and Thyrotropin Levels. The ELISA is further studied across Clinical and Nonclinical. The Radioimmunoassay is further studied across Autoantibodies Against Thyrotropin Receptor, Human Serum Thyroglobulin Autoantibodies, and Thyroperoxidase Autoantibodies. The Radioimmunoassay is projected to witness significant market share during forecast period.

Based on Disease Area, market is studied across Cancer, Cardiovascular Diseases, Endometriosis, Inflammatory Bowel Disease, Lupus, and Rheumatoid Arthritis. The Endometriosis is projected to witness significant market share during forecast period.

Based on Detection Range, market is studied across cCRP, Conventional CRP, and hs-CRP. The hs-CRP is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, and Laboratories. The Clinics is further studied across Entity. The Entity is further studied across Physician Offices and Small Clinics. The Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global C-Reactive Protein Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global C-Reactive Protein Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global C-Reactive Protein Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global C-Reactive Protein Testing Market?

4. What is the competitive strategic window for opportunities in the Global C-Reactive Protein Testing Market?

5. What are the technology trends and regulatory frameworks in the Global C-Reactive Protein Testing Market?

6. What is the market share of the leading vendors in the Global C-Reactive Protein Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global C-Reactive Protein Testing Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. C-Reactive Protein Testing Market, by Assay Type, 2022 vs 2030
4.3. C-Reactive Protein Testing Market, by Disease Area, 2022 vs 2030
4.4. C-Reactive Protein Testing Market, by Detection Range, 2022 vs 2030
4.5. C-Reactive Protein Testing Market, by End-User, 2022 vs 2030
4.6. C-Reactive Protein Testing Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Need to measure inflammation caused by a wide variety of health conditions
  - 5.1.1.2. Rising incidence of chronic disorders and growing geriatric population
  - 5.1.1.3. Improvements in C-reactive protein point-of-care testing for safely reducing antibiotics
- 5.1.2. Restraints
  - 5.1.2.1. Availability of more commercialized alternative disease testing methods
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements pertaining to conventional CRP tests
  - 5.1.3.2. Research on C-reactive protein in gastrointestinal diseases of dogs
- 5.1.4. Challenges
  - 5.1.4.1. Careful administration and handling requirements
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. C-Reactive Protein Testing Market, by Assay Type

6.1. Introduction
6.2. Chemiluminescence Immunoassay
- 6.2.1. Free T3
- 6.2.2. Free T4
- 6.2.3. Thyrotropin Levels
6.3. ELISA
- 6.3.1. Clinical
- 6.3.2. Nonclinical
6.4. Immunoturbidimetric Assay
6.5. Radioimmunoassay
- 6.5.1. Autoantibodies Against Thyrotropin Receptor
- 6.5.2. Human Serum Thyroglobulin Autoantibodies
- 6.5.3. Thyroperoxidase Autoantibodies

7. C-Reactive Protein Testing Market, by Disease Area

7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Diseases
7.4. Endometriosis
7.5. Inflammatory Bowel Disease
7.6. Lupus
7.7. Rheumatoid Arthritis

8. C-Reactive Protein Testing Market, by Detection Range

8.1. Introduction
8.2. cCRP
8.3. Conventional CRP
8.4. hs-CRP

9. C-Reactive Protein Testing Market, by End-User

9.1. Introduction
9.2. Assisted Living Healthcare Facilities
9.3. Clinics
- 9.3.1. Entity
  - 9.3.1.1. Physician Offices
  - 9.3.1.2. Small Clinics
9.4. Home
9.5. Hospitals
9.6. Laboratories

10. Americas C-Reactive Protein Testing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific C-Reactive Protein Testing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa C-Reactive Protein Testing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

C反応性蛋白質検査市場：アッセイタイプ、疾患領域、検出範囲、エンドユーザー別-2023-2030年の世界予測

C-Reactive Protein Testing Market by Assay Type, Disease Area, Detection Range, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 C反応性蛋白質検査市場アッセイタイプ別

第7章 C反応性蛋白質検査市場疾患領域別

第8章 C反応性蛋白質検査市場検知範囲別

第9章 C反応性蛋白質検査市場：エンドユーザー別

第10章 南北アメリカのC反応性蛋白質検査市場

第11章 アジア太平洋地域のC反応性蛋白質検査市場

第12章 欧州・中東・アフリカのC反応性蛋白質検査市場

第13章 競合情勢

第14章 掲載企業一覧

第15章 付録